Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
piroxicam cinnamate
- Development stage
- Unknown
- Lead developer
- Società Prodotti Antibiotici
- Modality
- Small Molecules
- Administration
- Oral, Rectal
01
Overview
Piroxicam cinnamate, also known as Cinnoxicam, is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class. It acts as a cyclooxygenase (COX) inhibitor, targeting both COX1 and COX2 enzymes to reduce the synthesis of prostaglandins involved in pain and inflammation. Piroxicam cinnamate is used primarily for the treatment of pain and inflammation associated with rheumatic disorders such as osteoarthritis and other inflammatory-degenerative osteoarticular diseases. It has been marketed in Italy by SPA for these indications. The drug is considered a long-acting prodrug form of piroxicam, designed to improve tolerability while maintaining efficacy[1][3][4][5].
- Brand names
- CinnoxicamSinartrol
- Other names
- piroxicam cinnamateCinnoxicamSinartrolSPA-S-510SPA-S510SPA-S 510
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on piroxicam cinnamate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on piroxicam cinnamate.